Diabetes 51:449-454, 2002
© 2002 by the American Diabetes Association, Inc.
Acyl-CoA Binding Protein Expression Is Fiber Type- Specific and Elevated in Muscles From the Obese Insulin-Resistant Zucker Rat
Jesper Franch1,
Jens Knudsen2,
Bronwyn A. Ellis3,
Preben K. Pedersen1,
Gregory J. Cooney3, and
Jørgen Jensen4
1 Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
2 Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
3 Garvan Institute of Medical Research, St. Vincents Hospital, Sydney, New South Wales, Australia
4 Department of Physiology, National Institute of Occupational Health, Oslo, Norway
Accumulation of acyl-CoA is hypothesized to be involved in development of insulin resistance. Acyl-CoA binds to acyl-CoA binding protein (ACBP) with high affinity, and therefore knowledge about ACBP concentration is important for interpreting acyl-CoA data. In the present study, we used a sandwich enzyme-linked immunosorbent assay to quantify ACBP concentration in different muscle fiber types. Furthermore, ACBP concentration was compared in muscles from lean and obese Zucker rats. Expression of ACBP was highest in the slow-twitch oxidative soleus muscle and lowest in the fast-twitch glycolytic white gastrocnemius (0.46 ± 0.02 and 0.16 ± 0.005 µg/mg protein, respectively). Expression of ACBP was soleus > red gastrocnemius > extensor digitorum longus > white gastrocnemius. Similar fiber type differences were found for carnitine palmitoyl transferase (CPT)-1, and a correlation was observed between ACBP and CPT-1. Muscles from obese Zucker rats had twice the triglyceride content, had approximately twice the long-chain acyl CoA content, and were severely insulin resistant. ACBP concentration was 30% higher in all muscles from obese rats. Activities of CPT-1 and 3-hydroxy-acyl-CoA dehydrogenase were increased in muscles from obese rats, whereas citrate synthase activity was similar. In conclusion, ACBP expression is fiber type-specific with the highest concentration in oxidative muscles and the lowest in glycolytic muscles. The 90% increase in the concentration of acyl-CoA in obese Zucker muscle compared with only a 30% increase in the concentration of ACBP supports the hypothesis that an increased concentration of free acyl-CoA is involved in the development of insulin resistance.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. P. Thyfault, M. G. Cree, D. Zheng, J. J. Zwetsloot, E. B. Tapscott, T. R. Koves, O. Ilkayeva, R. R. Wolfe, D. M. Muoio, and G. L. Dohm
Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism
Am J Physiol Cell Physiol,
February 1, 2007;
292(2):
C729 - C739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles
Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity
Endocr. Rev.,
May 1, 2006;
27(3):
318 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Beha, H.-P. Juretschke, J. Kuhlmann, C. Neumann-Haefelin, U. Belz, M. Gerl, W. Kramer, M. Roden, and A. W. Herling
Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E989 - E997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kiens
Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance
Physiol Rev,
January 1, 2006;
86(1):
205 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ciapaite, G. Van Eikenhorst, S. J.L. Bakker, M. Diamant, R. J. Heine, M. J. Wagner, H. V. Westerhoff, and K. Krab
Modular Kinetic Analysis of the Adenine Nucleotide Translocator-Mediated Effects of Palmitoyl-CoA on the Oxidative Phosphorylation in Isolated Rat Liver Mitochondria
Diabetes,
April 1, 2005;
54(4):
944 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Kim, J. J. Fillmore, O. Gavrilova, L. Chao, T. Higashimori, H. Choi, H.-J. Kim, C. Yu, Y. Chen, X. Qu, et al.
Differential Effects of Rosiglitazone on Skeletal Muscle and Liver Insulin Resistance in A-ZIP/F-1 Fatless Mice
Diabetes,
June 1, 2003;
52(6):
1311 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|